1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HDAC2 CTRPv2 pan-cancer AAC 0.21 3e-09
mRNA ARHGAP33 CTRPv2 pan-cancer AAC 0.21 3e-09
mRNA KMT5C CTRPv2 pan-cancer AAC 0.21 3e-09
mRNA GP1BB CTRPv2 pan-cancer AAC 0.22 3e-09
mRNA KIF1A CTRPv2 pan-cancer AAC 0.22 3e-09
mRNA SUGP2 CTRPv2 pan-cancer AAC 0.24 3e-09
mRNA MBTD1 CTRPv2 pan-cancer AAC 0.24 3e-09
mRNA ILF3 CTRPv2 pan-cancer AAC 0.23 5e-09
mRNA MYB CTRPv2 pan-cancer AAC 0.24 5e-09
mRNA DNMT3A CTRPv2 pan-cancer AAC 0.22 6e-09
Download CSV